Bayer and Vividion to unveil breakthroughs in targeted cancer therapies at AACR 2025
Bayer and Vividion Therapeutics, Inc. will present the latest research on their advancing oncology portfolio at the upcoming American Association for Cancer Research (AACR) 2025 Annual Meeting, taking place… read more.